- Home
- BANC vs ZLAB Comparison
BANC vs ZLAB Comparison
Compare BANC & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BANC | ZLAB |
|---|---|---|
| Founded | 1941 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.6B |
| IPO Year | 2002 | 2017 |
Fundamental Metrics
Financial Performance| Metric | BANC | ZLAB |
|---|---|---|
| Price | $17.49 | $25.50 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 12 |
| Target Price | $22.00 | ★ $33.14 |
| AVG Volume (30 Days) | ★ 2.0M | 698.4K |
| Earning Date | 10-21-2026 | 11-05-2026 |
| Dividend Yield | ★ 2.79% | N/A |
| EPS Growth | ★ 125.00 | 38.46 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,818,792,000.00 | $460,156,000.00 |
| Revenue This Year | $3.93 | N/A |
| Revenue Next Year | $11.48 | $26.50 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 15.33 |
| 52 Week Low | $15.33 | $15.96 |
| 52 Week High | $21.93 | $34.07 |
Technical Indicators
Market Signals| Indicator | BANC | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 27.73 | 58.51 |
| Support Level | $16.35 | $24.81 |
| Resistance Level | $19.16 | $27.20 |
| Average True Range (ATR) | 0.40 | 0.77 |
| MACD | -0.09 | -0.03 |
| Stochastic Oscillator | 0.00 | 76.31 |
Price Performance
Historical ComparisonAbout BANC Banc of California Inc.
Banc of California Inc is a financial holding company. It offers banking and financial services. Its services include banking services, lending services, and private banking services. Its deposit and banking product and service offerings include checking, savings, money market, certificates of deposit, and retirement accounts. Lending activities are focused on providing financing to California's diverse private businesses, entrepreneurs, and communities, and loans are often secured by California commercial and residential real estate. The company has one reportable segment named Commercial banking.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.